F/m Emerald Life Sciences Innovation ETF
F/m Emerald Life Sciences Innovation ETF reported 43 holdings worth US$105M as of May 31, 2026 (Form N-PORT)
As of May 31, 2026 · Filed Jul 28, 2026
F/m Emerald Life Sciences Innovation ETF reported 43 holdings worth US$105M as of May 31, 2026. Largest: Travere Therapeutics, Inc., Cogent Biosciences, Inc. and Livanova Plc. Filed Jul 28, 2026 (Form N-PORT).
- Holdings
- 43
- Value as reported
- US$105M
The filing in full
| Company | Shares | Value as reported | % of portfolio |
|---|
| Travere Therapeutics, Inc. | 171K | US$8.05M | 7.7% |
| Cogent Biosciences, Inc. | 226K | US$7.91M | 7.5% |
| Livanova Plc | 101K | US$7.47M | 7.1% |
| Spyre Therapeutics, Inc. | 91,588 | US$6.73M | 6.4% |
| Guardant Health, Inc. | 44,694 | US$5.8M | 5.5% |
| Mirum Pharmaceuticals, Inc. | 50,911 | US$5.17M | 4.9% |
| Corcept Therapeutics Incorporated | 72,454 | US$5.03M | 4.8% |
| United Therapeutics Corporation | 7,841 | US$4.37M | 4.2% |
| Veradermics, Incorporated | 35,568 | US$3.59M | 3.4% |
| Savara, Inc. | 651K | US$3.39M | 3.2% |
| Cytokinetics, Incorporated | 43,268 | US$3.32M | 3.2% |
| Nektar Therapeutics | 50,876 | US$3.3M | 3.1% |
| Trevi Therapeutics, Inc. | 232K | US$3.27M | 3.1% |
| Dianthus Therapeutics, Inc. | 34,884 | US$3.24M | 3.1% |
| Axsome Therapeutics, Inc. | 12,723 | US$2.98M | 2.8% |
| Billiontoone, Inc. | 29,023 | US$2.87M | 2.7% |
| Transmedics Group, Inc. | 41,894 | US$2.82M | 2.7% |
| Viridian Therapeutics, Inc. | 133K | US$2.35M | 2.2% |
| Icu Medical, Inc. | 16,227 | US$2.2M | 2.1% |
| Corvus Pharmaceuticals, Inc. | 165K | US$2.05M | 2.0% |
| Palvella Therapeutics, Inc. | 17,254 | US$2.04M | 1.9% |
| Ceribell, Inc. | 88,354 | US$1.63M | 1.6% |
| Globus Medical, Inc. | 16,258 | US$1.33M | 1.3% |
| Xeris Biopharma Holdings, Inc. | 208K | US$1.28M | 1.2% |
| Bridgebio Pharma, Inc. | 18,534 | US$1.23M | 1.2% |
| Integer Holdings Corporation | 13,436 | US$1.2M | 1.1% |
| Twist Bioscience Corporation | 17,850 | US$1.19M | 1.1% |
| Waystar Holding Corp. | 55,155 | US$1.1M | 1.0% |
| Wave Life Sciences Ltd. | 152K | US$1M | 0.95% |
| Hinge Health, Inc. | 17,590 | US$989K | 0.94% |
| Korro Bio, Inc. | 62,855 | US$843K | 0.80% |
| Radnet, Inc. | 14,899 | US$827K | 0.79% |
| Aveanna Healthcare Holdings Inc. | 106K | US$758K | 0.72% |
| Lumexa Imaging Holdings, Inc. | 94,977 | US$739K | 0.70% |
| Insmed Incorporated | 6,050 | US$647K | 0.62% |
| Alphatec Holdings, Inc. | 77,386 | US$600K | 0.57% |
| Neogenomics, Inc. | 43,071 | US$453K | 0.43% |
| Alamar Biosciences, Inc. | 9,442 | US$193K | 0.18% |
| Collegium Pharmaceutical, Inc. | 0 | US$0 | 0.00% |
| Acadia Pharmaceuticals Inc. | 0 | US$0 | 0.00% |
| Soleno Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Madrigal Pharmaceuticals, Inc. | 0 | US$0 | 0.00% |
| Kalvista Pharmaceuticals, Inc. | 0 | US$0 | 0.00% |
Source
View original at SEC
Related